Does lowering lipoprotein(a) have an impact on cardiovascular risk?

+Practice
In print
Heartbeat

Does lowering lipoprotein(a) have an impact on cardiovascular risk?

Chris Ellis

Chris Ellis

Heartbeat-ECG-Feb
ECG supplied

Consultant cardiologist Chris Ellis looks at what we know and what we don’t know about lipoproteins, cardiovascular risk and optimal management

Key points, Lipoprotein(a) is a circulating lipoprotein that predicts atherosclerotic disease, cardiovascular events and aortic valve stenosis. New drugs can lo, Pract Green w Pale Yellow
References

1. Katsiki N, Vrablik M, Banach M, et al. Inclisiran, low-density lipoprotein cholesterol and lipoprotein (a). Pharmaceuticals (Basel) 2023;16(4):577.

2. O’Riordan M. Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360. TCTMD, 18 November 2024.

3. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):111–88.